David Wohlberg

ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.

Spectral Molecular Imaging, Inc. is a medical imaging device company. It manufactures diagnostic imaging products based on spectral optical imaging. The company was founded in 2004 and is located in Los Angeles, CA

Israel Investment Fund Group LLC (IIFG) is an private equity/venture capital firm founded in 2018 by Hiri Etessami. The firm is headquartered in Beverly Hills, CA.